LIN Stock Analysis: Linde Ordinary Shares | NASDAQ
Specialty Chemicals | NASDAQ, USA | Market Cap: 225.871m USD | 12M Return: 2.7% | IE000S9YS762 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.02B
EPS Trend: 99.6%
Qual. Beats: 0
Rev. Trend: 88.9%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Linde plc is a global industrial gas company headquartered in Woking, United Kingdom, and founded in 1879. It produces and supplies atmospheric gases (oxygen, nitrogen, argon, and rare gases) as well as process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. Beyond gas production, the company designs and builds turnkey process plants-including air separation, hydrogen, synthesis, olefin, and natural gas facilities-for both third-party customers and its own operations.
Its customer base spans healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics, with operations across the United States, Brazil, Mexico, Canada, Germany, the United Kingdom, Eastern Europe, China, Australia, South Korea, and India. As a member of the GICS Industrial Gases sub-industry, the industrial gases sector is generally characterized by high capital intensity, long-term contracts, and significant barriers to entry, with Linde being one of a small number of global producers alongside competitors such as Air Liquide and Air Products.
- Industrial gas volumes track global manufacturing PMI cycles
- Hydrogen clean energy project backlog drives new revenue growth
- Healthcare electronics specialty gas demand expands higher margin sales
| Net Income: 7.29b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.26 > 1.0 |
| NWC/Revenue: -5.50% < 20% (prev -3.27%; Δ -2.23% < -1%) |
| CFO/TA 0.12 > 3% & CFO 10.5b > Net Income 7.29b |
| Net Debt (24.2b) to EBITDA (13.5b): 1.80 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (464.5m) vs 12m ago -1.91% < -2% |
| Gross Margin: 45.64% > 18% (prev 40.08%; Δ 5.56% > 0.5%) |
| Asset Turnover: 40.65% > 50% (prev 38.62%; Δ 2.02% > 0%) |
| Interest Coverage Ratio: 36.01 > 6 (EBIT TTM 9.65b / Interest Expense TTM 268.0m) |
| A: -0.02 (Total Current Assets 14.2b - Total Current Liabilities 16.1b) / Total Assets 88.3b |
| B: 0.21 (Retained Earnings 18.8b / Total Assets 88.3b) |
| C: 0.11 (EBIT TTM 9.65b / Avg Total Assets 87.2b) |
| D: 0.82 (Book Value of Equity 39.1b / Total Liabilities 47.7b) |
| Altman-Z'' = 2.15 = BBB |
| DSRI: 1.04 (Receivables 6.06b/5.49b, Revenue 35.4b/33.2b) |
| GMI: 0.88 (GM 40.08% / 45.64%) |
| AQI: 0.96 (AQ_t 0.51 / AQ_t-1 0.53) |
| SGI: 1.07 (Revenue 35.4b / 33.2b) |
| TATA: -0.04 (NI 7.29b - CFO 10.5b) / TA 88.3b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of August 13, 2026, the stock is trading at USD 479.43 with a total of 2,312,365 shares traded. Over the past week, the price has changed by -2.37%, over one month by -8.52%, over three months by -4.55% and over the past year by +2.67%.
Current recommended Stop Loss: 463.60 (which is 3.3% or 1.5 ATR below the current price).
Linde Ordinary Shares has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy LIN.
- StrongBuy: 12
- Buy: 6
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 548 | 14.3% |
P/E Trailing = 31.6525
P/E Forward = 27.027
P/S = 6.3717
P/B = 5.7166
P/EG = 2.0656
Revenue TTM = 35.4b USD
EBIT TTM = 9.65b USD
EBITDA TTM = 13.5b USD
Long Term Debt = 20.7b USD (from longTermDebt, last quarter)
Short Term Debt = 7.33b USD (from shortTermDebt, last quarter)
Debt = 29.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.08b
Net Debt = 24.2b USD (calculated: Debt 29.1b - CCE 4.90b)
Enterprise Value = 250b USD (226b + Debt 29.1b - CCE 4.90b)
Interest Coverage Ratio = 36.01 (Ebit TTM 9.65b / Interest Expense TTM 268.0m)
EV/FCF = 50.26x (Enterprise Value 250b / FCF TTM 4.97b)
FCF Yield = 1.99% (FCF TTM 4.97b / Enterprise Value 250b)
FCF Margin = 14.03% (FCF TTM 4.97b / Revenue TTM 35.4b)
Net Margin = 20.56% (Net Income TTM 7.29b / Revenue TTM 35.4b)
Gross Margin = 45.64% ((Revenue TTM 35.4b - Cost of Revenue TTM 19.3b) / Revenue TTM)
Gross Margin QoQ = 47.67% (prev 48.49%)
Tobins Q-Ratio = 2.83 (Enterprise Value 250b / Total Assets 88.3b)
Interest Expense / Debt = 0.92% (Interest Expense 268.0m / Debt 29.1b)
Taxrate = 22.23% (2.09b / 9.38b)
NOPAT = 7.51b (EBIT 9.65b * (1 - 22.23%))
Current Ratio = 0.88 (Total Current Assets 14.2b / Total Current Liabilities 16.1b)
Debt / Equity = 0.74 (Debt 29.1b / totalStockholderEquity, last quarter 39.1b)
Debt / EBITDA = 1.80 (Net Debt 24.2b / EBITDA 13.5b)
Debt / FCF = 4.86 (Net Debt 24.2b / FCF TTM 4.97b)
Total Stockholder Equity = 38.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.36% (Net Income 7.29b / Total Assets 88.3b)
RoE = 18.87% (Net Income TTM 7.29b / Total Stockholder Equity 38.6b)
RoCE = 16.28% (EBIT 9.65b / Capital Employed (Equity 38.6b + L.T.Debt 20.7b))
RoIC = 9.65% (NOPAT 7.51b / Invested Capital 77.8b)
WACC = 5.91% (E(226b)/V(255b) * Re(6.58%) + D(29.1b)/V(255b) * Rd(0.92%) * (1-Tc(0.22)))
Discount Rate = 6.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.95 | Cagr: -1.95%
[DCF] Terminal Value 75.19% ; FCFF base≈5.01b ; Y1≈4.96b ; Y5≈5.09b
[DCF] Fair Price = 119.8 (EV 79.4b - Net Debt 24.2b = Equity 55.2b / Shares 461.0m; r=8.35% [WACC [floored]]; 5y FCF grow -1.85% → 2.50% )
EPS Correlation: 99.63 | EPS CAGR: 7.96% | SUE: 0.64 | # QB: 0
Revenue Correlation: 88.94 | Revenue CAGR: 2.60% | SUE: 1.93 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=-100.00% | Revisions=+36% | Analysts=17
EPS current Year (2026-12-31): EPS=0.00 | Chg30d=-100.00% | Revisions=+21% | GrowthEPS=+8.6% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=18.32 | Chg30d=+0.05% | Revisions=+17% | GrowthEPS=+10.9% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +32% (up=15, down=7)